Wed, April 8, 2009
Tue, April 7, 2009
Mon, April 6, 2009
Fri, April 3, 2009
Thu, April 2, 2009
Wed, April 1, 2009
Tue, March 31, 2009
Mon, March 30, 2009
Fri, March 27, 2009
Thu, March 26, 2009
Wed, March 25, 2009
Tue, March 24, 2009
Mon, March 23, 2009
Fri, March 20, 2009
Thu, March 19, 2009
Wed, March 18, 2009

Cypress Bioscience, Inc.: Cypress Bioscience, Inc. to Present at Citi's 4th Annual Biotech Day

SAN DIEGO, CA--(Marketwire - March 30, 2009) - Cypress Bioscience, Inc. (NASDAQ: [ CYPB ]) today announced that Michael R. Hufford, PhD, its Vice President of Corporate Development, will present at Citi's 4th Annual Biotech Day on April 1, 2009.

The Citi conference is being held in New York City. Dr. Hufford is scheduled to present on Wednesday, April 1st at 10:00 a.m. Eastern Time. The audio broadcast of this presentation can be accessed at [ http://www.veracast.com/webcasts/citigroup/biotech09/29103305.cfm ].

A replay of the presentation will be available at the same web address as well as on Cypress' website, [ http://www.cypressbio.com/events.php ].

About Cypress Bioscience

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella™ (milnacipran HCI) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at [ www.cypressbio.com ].



Similar Health and Fitness Publications